Effect of metoprolol combined with trimetazidine on serum angiotensin Ⅱ and vascular endothelial function in patients with chronic heart failure

QIU Qingyan; DAI Min; MOU Ying; YU Hui

doi:10.7619/jcmp.20200912

Journal of Clinical Medicine in Practice > 2021 > 25(3): 99-102, 106. > DOI: 10.7619/jcmp.20200912

QIU Qingyan, DAI Min, MOU Ying, YU Hui. Effect of metoprolol combined with trimetazidine on serum angiotensin Ⅱ and vascular endothelial function in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 99-102, 106. DOI: 10.7619/jcmp.20200912

Citation:

PDF (750 KB)

Effect of metoprolol combined with trimetazidine on serum angiotensin Ⅱ and vascular endothelial function in patients with chronic heart failure

Department of Cardiovascular Medicine, Mianyang City Central Hospital in Sichuan Province, Mianyang, Sichuan, 621000

More Information

Received Date: November 21, 2020
Available Online: March 03, 2021
Published Date: March 03, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the effect of metoprolol combined with trimetazidine on serum angiotensin Ⅱ (Ang Ⅱ) and vascular endothelial function in patients with chronic heart failure (CHF).
Methods Totally 136 CHF patients were randomly divided into control group and experimental group, with 68 cases in each group. The control group was given basic therapeutic measures and metoprolol, while the experimental group was given trimetazidine on the basis of the control group. Left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDd), left ventricular end systolic diameter (LVESD), N-terminal pro-B type natriuretic peptide (NT-ProBNP), 6-minute walking distance, the level of Ang Ⅱ, endothelial flow-mediated dilation (FMD) of brachial artery, the levels of plasma nitric oxide (NO) and endothelin-1 (ET-1), clinical efficacy and adverse reactions were compared between the two groups before and after treatment.
Results Two cases in both groups dropped out of the study. After treatment, LVEDd, LVESD and NT-ProBNP level of the experimental group were significantly lower than those of the control group, while the LVEF and 6-minute walking distance were significantly higher than those of the control group (P < 0.05). After treatment, Ang Ⅱ and ET-1 levels in the experimental group were significantly lower than those in the control group, while FMD and NO levels were significantly higher than those in the control group (P < 0.05). The total effective rate of the experimental group was 95.45%, which was significantly higher than 84.85% of the control group (P < 0.05). The incidence of adverse reactions was 10.61% in the experimental group, which showed no significant difference when compared to 6.06% in the control group (P>0.05).
Conclusion Metoprolol combined with trimetazidine is safe and effective in the treatment of CHF patients, which can improve the heart function and vascular endothelial function and enhance the therapeutic effect.
- metoprolol,
- trimetazidine,
- chronic heart failure,
- endothelial function,
- left ventricular ejection fraction

FullText(HTML)

References (18)

References

[1]	何飞, 周新浪, 陈达开, 等. 运动康复训练对冠心病慢性心力衰竭患者心功能的影响[J]. 中华物理医学与康复杂志, 2019, 41(1): 58-60.
[2]	KOKKI H, MAAROOS M, ELLAM S, et al. How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients[J]. Eur J Clin Pharmacol, 2018, 74(6): 785-792. doi: 10.1007/s00228-018-2437-1
[3]	POULUSSEN F C P, PETERS B J, HUA K H, et al. The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population[J]. Pharmacogenetics Genom, 2019, 29(7): 179-182. doi: 10.1097/FPC.0000000000000381
[4]	蔡俊, 朱怀军, 聂力, 等. 基于线性混合模型定量分析帕罗西汀与美托洛尔的药物相互作用[J]. 中国医院药学杂志, 2019, 39(20): 2054-2058.
[5]	COSMI F, SHEN L, MAGNOLI M, et al. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes[J]. Eur J Heart Fail, 2018, 20(5): 888-895. doi: 10.1002/ejhf.1146
[6]	马骏, 苏兴, 王芬, 等. 游离脂肪酸与老年慢性心力衰竭患者焦虑和抑郁的相关性分析[J]. 中华老年医学杂志, 2019, 38(7): 733-736. doi: 10.3760/cma.j.issn.0254-9026.2019.07.005
[7]	CHARACH G, ROGOWSKI O, KARNIEL E, et al. Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: a cohort study[J]. Medicine, 2019, 98(38): e17108. doi: 10.1097/MD.0000000000017108
[8]	ARSLAN H. Invited response on: "several opinions on effects of insulin, metoprolol and deferoxamine on fat graft"[J]. Aesthetic Plast Surg, 2019, 43(5): 1413-1414. doi: 10.1007/s00266-019-01430-5
[9]	YANG Y, LI N, CHEN T, et al. Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway[J]. Pharm Biol, 2019, 57(1): 625-631. doi: 10.1080/13880209.2019.1657905
[10]	崔彩, 吴翠平, 王晨宇. 美托洛尔联合有氧运动改善高血压患者骨骼肌功能性抗交感及运动能力的疗效观察[J]. 中华物理医学与康复杂志, 2019, 41(7): 526-531. doi: 10.3760/cma.j.issn.0254-1424.2019.07.012
[11]	INCE S, DEMIRKOL S, KARACALIOGLU A O, et al. Does oral metoprolol have any effect on the functional parameters and perfusion defects of the left ventricle[J]. Curr Med Imaging Rev, 2018, 14(2): 309-316. doi: 10.2174/1573405613666170712145228
[12]	窦丹燕. 法舒地尔联合曲美他嗪对心力衰竭患者的临床研究[J]. 中国临床药理学杂志, 2019, 35(18): 1976-1978, 2005.
[13]	GLEZER M, CHOICE-2 study investigators. The effectiveness of trimetazidine treatment in patients with stable angina pectoris of various durations: results from the CHOICE-2 study[J]. Adv Ther, 2018, 35(7): 1103-1113. doi: 10.1007/s12325-018-0674-4
[14]	LI B, YANG Z B, LEI S S, et al. Combined antihypertensive effect of paeoniflorin enriched extract and metoprolol in spontaneously hypertensive rats[J]. Pharmacogn Mag, 2018, 14(53): 44-52. doi: 10.4103/pm.pm_483_16
[15]	乔香瑞, 刘军辉, 花蕊, 等. 循环单核细胞和血浆中GDF-15和NT-proBNP对慢性心力衰竭的诊断及心血管事件的预测价值[J]. 南方医科大学学报, 2019, 39(11): 1273-1279.
[16]	SCHULZ M, GRIESE-MAMMEN N, BÖHM M, et al. Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply[J]. Eur J Heart Fail, 2020, 22(3): 565-566.
[17]	EDVINSSON M L, STENBERG A, ÅSTRÖM-OLSSON K. Improved outcome with standardized plan for clinical management of acute decompensated chronic heart failure[J]. J Geriatr Cardiol, 2019, 16(1): 12-18. http://www.ixueshu.com/document/90e2dbb65f479b62208ef9f1ca869fa8318947a18e7f9386.html
[18]	DENG H, OUYANG W, ZHANG L, et al. LncRNA GASL1 is downregulated in chronic heart failure and regulates cardiomyocyte apoptosis[J]. Cell Mol Biol Lett, 2019, 24: 41-48. doi: 10.1186/s11658-019-0165-x

Cited By

Cited by

Periodical cited type(15)

1.	高淑彦，赵瑞芳，李文静，刘倩楠，沈青青. 阿托伐他汀钙联合环磷腺苷与托拉塞米治疗老年慢性心功能不全的疗效及对血清BNP、Gal-3、sICAM-1水平的影响. 临床和实验医学杂志. 2025(01): 5-9 .
2.	谢兆莉，张耀堂，苏书艳. 环磷腺苷葡胺联合新四联方案治疗慢性心力衰竭的疗效及对心功能指标的影响. 临床合理用药. 2025(08): 16-19 .
3.	田茂婷，朱应华. 沙库巴曲缬沙坦联合环磷腺苷葡胺对老年慢性心力衰竭患者心率变异性及心功能的影响. 中外医疗. 2024(03): 104-107 .
4.	李树云，刘爱环，郝玲. 卡托普利与左西孟旦共同治疗慢性心力衰竭的效果. 慢性病学杂志. 2024(05): 755-758 .
5.	王坤，孔令才，许林艳，王磊. 心脉隆注射液联合环磷腺苷葡胺治疗高龄慢性心力衰竭效果分析. 世界复合医学(中英文). 2024(02): 9-12 .
6.	王斌. 注射用环磷腺苷葡胺联合复窦合剂对急性心肌梗死后心律失常的应用效果及对QRS波时限、左室射血分数水平影响. 中华养生保健. 2024(16): 53-56 .
7.	葛梦芸. 氧化樟脑注射液联合环磷腺苷葡胺治疗心力衰竭的临床疗效分析. 北方药学. 2024(11): 149-151 .
8.	应璇，贾彩乐，何好权，陈舒，刘俊. 麝香通心滴丸联合沙库巴曲缬沙坦对慢性心力衰竭患者的临床疗效观察. 浙江医学. 2023(06): 617-620 .
9.	窦东锋，刘洪光，张丽芬. 单硝酸异山梨酯联合培哚普利叔丁胺治疗老年慢性心力衰竭患者的疗效. 国际医药卫生导报. 2023(09): 1276-1280 .
10.	赵智慧，宋雨，吴东彬，王娇娇. 冠心宁联合单硝酸异山梨酯治疗慢性心力衰竭患者临床疗效及对心功能的影响. 药学研究. 2023(05): 348-351 .
11.	祖建杰. 卡维地洛联合硝酸异山梨酯在治疗重症心力衰竭中的疗效及其对血清CXCL10和CXCL12水平的影响. 检验医学与临床. 2023(20): 3033-3036 .
12.	刘长英. 左西孟旦与环磷腺苷葡胺联合治疗顽固性心力衰竭的临床观察. 大医生. 2023(22): 56-58 .
13.	郭城楠. 慢性心力衰竭药物治疗临床研究进展. 天津药学. 2022(04): 64-69 .
14.	韩勇，郭艳涛. 单硝酸异山梨酯联合培哚普利叔丁胺治疗慢性心力衰竭的疗效. 深圳中西医结合杂志. 2022(15): 96-99 .
15.	朱明. 环磷腺苷葡胺对老年慢性心力衰竭治疗效果. 现代诊断与治疗. 2022(23): 3533-3536 .

Other cited types(2)

Get Citation

PDF

XML

Article views (363) PDF downloads (28) Cited by(17)

Turn off MathJax

Article Contents

Abstract

References

Effect of metoprolol combined with trimetazidine on serum angiotensin Ⅱ and vascular endothelial function in patients with chronic heart failure

Abstract

References

Cited by

Periodical cited type(15)

Other cited types(2)

Catalog

Export File

Citation

Format

Content